Transversus Abdominis Plane Block Using Dexmedetomidine and Bupivacaine

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 10, 2017

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Laparoscopic Orcheopexy
Interventions
DRUG

Dexmedetomidine

patients will receive ultrasound guided TAP block using 0.3 ml/kg bupivacaine (0.125%) with a maximum volume of 20 ml + 0.25 mg/kg dexmedetomidine dissolved in 2 ml normal saline (0.9%)

DRUG

Bupivacaine

patients will receive ultrasound guided TAP block using 0.3 ml/kg bupivacaine (0.125%) with a maximum volume of 20 ml + 2 ml normal saline (0.9%)

Trial Locations (1)

Unknown

Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03156296 - Transversus Abdominis Plane Block Using Dexmedetomidine and Bupivacaine | Biotech Hunter | Biotech Hunter